Development and characterization of a carvedilol-loaded self-microemulsifying delivery system

Clinical Research and Regulatory Affairs

Volumn 26, Issue 3, 2009, Pages 50-64

  Singh, Sandeep Kumar ^a   Verma, Priya Ranjan Prasad ^a   Razdan, Balkishen ^b  

^a BIRLA INSTITUTE OF TECHNOLOGY   (India)

^b Sardar Bhagwan Singh Post Gratudate Institute of Biomedical Sciences & Research   (India)

Author keywords

Carvedilol; Characterization; Particle size distribution; Phase diagram; Release kinetics; Self microemulsifying drug delivery system

Indexed keywords

AMINE; CARVEDILOL; OIL; OLEYLAMINE; SURFACTANT; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; ARTICLE; CONTACT ANGLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSE REFLECTANCE SPECTROSCOPY; DISSOLUTION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INCOMPATIBILITY; INFRARED SPECTROSCOPY; MICROEMULSION; NANOTECHNOLOGY; PARTICLE SIZE; SELF MICROEMULSIFYING DELIVERY SYSTEM; SOLUBILITY; SPECTROSCOPY; SURFACE PROPERTY; TIME; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 72449150202     PISSN: 10601333     EISSN: 15322521     Source Type: Journal    
DOI: 10.1080/10601330903143942     Document Type: Article

References (34)

1. Schamp K, Schreder SV, Dressman J. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly water soluble lipophillic drug substance. Eur J Pharm Biopharm 2006;62:227-234.
2. Kubinhy H. Strategies and recent technologies in drug discovery. Pharmazie 1994;50:647-662.
3. Lipinsky CA, Lombardo F, Dominy BW, Feeney PI. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Disc Rev 1997;23:3-25.
4. Robinson JR. Semi-solid formulations for oral drug delivery. Bull Tech Gattefosse 1996;89:11-13.
5. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;21:233-246.
6. Aungst BJ. Novel formulations strategies for improving oral bioavailability of drugs with poor permeability or presystemic metabolism. J Pharm Sci 1993;82:979-987.
7. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanosuspension formulation. Eur J Pharm Biopharm 2007;66:227-243.
8. Pouton CW. Formulation of self emulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47-58.
9. Constantinides PP. Lipid microemulsion for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 1995;12:1561-1572.
10. Pouton CW. Lipid formulations for oral administrations of drugs: non-emulsifying, self-emulsifying and 'self- microemulsifying' drug delivery systems. Eur J Pharm Sci 2000;11:S93-S98.
11. Gershanik T, Benita S. Self dispersing lipid formulations for improving oral absorption of lipophillic drugs. Eur J Pharm Biopharm 2000;50:179-188.
12. Humberstone AJ, Charman WN. Lipid vehicles for the drug delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103-128.
13. O'Driscoll CM. Lipid based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 2002;15:405-415.
14. Swenson ES, Mehta SC, Radebaugh GW. Targeting lymphatic transport and modified systemic distribution of CI-976, a lipophillic lipid-regulator via a formulation approach. Int J Pharm 1994;108:85-93.
15. Grove M, Mullertz A, Nielsen JL, Pedersen GP. Bioavailability of seocalcitol II: development and characterization of selfmicroemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 2006;28:233-242.
16. Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of Self-Microemulsifying Drug Delivery Systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65-73.
17. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self emulsifying formulations of halofantrine. Int J Pharm 1998;167:155-164.
18. Itoh K, Matsui S, Tozuka Y, Oguchi T, Yamamoto K. Improvement of physicochemical properties of N-4472 Part II: characterization of N-4472 microemulsion and the enhanced oral absorption. Int J Pharm 2002;246:75-83.
19. Morgan T. Clinical pharmacokinetics and pharmacodynamics of Carvediol. Clin Pharmcokinetics 1994;66:335-346.
20. Neugebauer G, Akpan W. Pharmacokinetics and disposition of carvedilol in humans. J Card Pharm 1987;10:85-88.
21. Hardman JG, Limbird LE. Goodman & Gilman's The pharmcological basis of therapeutics. 10th ed. London and New York: McGraw-Hill International edition; 2001. p 255.
22. Tadolini B, Franconi F. Carvedilol inhibition of lipid peroxidation. A new antioxidant mechanism. Free Radic Res 1998;29:377-387.
23. Vrana A, Andrysek T. The effect of particle size on bioavailability in cyclosporine preparations based on submicron dispersions. Biomed Papers 2001;145:9-15.
24. Gershanik T, Benzeno S, Benita S. Interaction of the selfemulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharm Res 1998;15:863-869.
25. Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Contr Rel 2004;95:627-638.
26. Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self microemulsifying drug delivery system. Eur J Pharm Biopharm 2006;63:288-294.
27. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
28. Ahuja N, Katare, OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water soluble carriers. Eur J Pharm Biopharm 2007;65:26-38.
29. Khan N, Craig DQM. The influence of drug incorporation on the structure and release properties of solid dispersions in lipid matrices. J Contr Rel 2003;93:355-368.
30. Sultananta W, Craig DQM, Newton JM. The effects of ageing on the thermal behavior and mechanical properties of pharmaceutical glycerides. Int J Pharm 1994;111:51-62.
31. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P, Mooter VD. Physicochemical characterization of soild dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci 2000;10:311-322.
32. Barker SA, Yap SP, Yuen KH, McCoy CP, Murphy JR, Craig DQM. An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14. J Cont Rel 2003;91:477-488.
33. Francès C, Veiga MD, Espanol OM, Cadorniga R. Preparation, characterization and dissolution of ciprofloxacin/PEG 6000 binary systems. Int J Pharm 1991;77:193-198.
34. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Physicochemical characterization and dissolution of norfloxacin/ cyclodextrin inclusions compounds and PEG solid dispersions. Int J Pharm 1995;123:53-63.